You just read:

Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic Brainstem Glioma

News provided by

Burzynski Research Institute, Inc.

Oct 24, 2014, 05:50 ET